Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Volumn 16, Issue 4, 2010, Pages 588-599

  Meneghini, Luigi F ^a   Traylor, Louise ^b   Schwartz, Sherwyn L ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN; LIPID; METFORMIN; PIOGLITAZONE; SULFONYLUREA DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BODY MASS; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT; RANDOMIZED CONTROLLED TRIAL; TIME;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; MALE; METFORMIN; MIDDLE AGED; PATIENT DROPOUTS; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES; TIME FACTORS; YOUNG ADULT;

EID: 79952014960     PISSN: None     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP09281.OR     Document Type: Article

References (0)